prognosis of adverse events in patients with chronic heart failure is suspected

摘要

The present invention relates to the field of clinical diagnosis. The invention particularly relates to the prognosis of adverse events in patients with or suspected of having stable chronic heart failure by measuring procalcitonin (PCT) levels.